Elkhorn Partners Limited Partnership Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Elkhorn Partners Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$83.14 - $145.99 $20,785 - $36,497	250 Added 71.43%	600 $87,000
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $34,905 - $51,968	350 New	350 $48,000
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $65,780 - $105,020	-1,000 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$64.07 - $91.75 $64,069 - $91,750	1,000 New	1,000 $68,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Elkhorn Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Elkhorn Partners Limited Partnership with notifications on news.